Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
University of Kansas Medical Center
Study ID
NCT03794466
Status
Recruiting
Apply to this trial

Conditions

  • Pelvic Congestive Syndrome
  • Pelvic Pain

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.

Key Dates

Start date
May 10, 2019
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
30 participants (estimated)

Primary Outcome Measure

Quantify pain relief using the Pelvic Congestion Symptom Pain Scale after gonadal vein embolization [ Time Frame: Change from baseline (before gonadal vein embolization) to 360 days post-procedure. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Kansas Medical CenterKansas CityKansas66160
Carissa Walter, MPH
[email protected]
913-945-7450
Adam S Alli, MD (PRINCIPAL_INVESTIGATOR)
Daniel Kirkpatrick, MD (SUB_INVESTIGATOR)
Steven Lemons, MD (SUB_INVESTIGATOR)
Brandon Custer, MD (SUB_INVESTIGATOR)
Philip Johnson, MD (SUB_INVESTIGATOR)
Zachary Collins, MD (SUB_INVESTIGATOR)

Find similar trials in Kansas City, KS

By research site
The University of Kansas Medical Center· Kansas City, KS

Related Studies